Cargando…
Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847067/ https://www.ncbi.nlm.nih.gov/pubmed/35172125 http://dx.doi.org/10.1016/j.ccell.2022.02.005 |
| _version_ | 1784651968848855040 |
|---|---|
| author | Canti, Lorenzo Ariën, Kevin K. Desombere, Isabelle Humblet-Baron, Stéphanie Pannus, Pieter Heyndrickx, Leo Henry, Aurélie Servais, Sophie Willems, Evelyne Ehx, Grégory Goriely, Stanislas Seidel, Laurence Michiels, Johan Willems, Betty Goossens, Maria E. Beguin, Yves Marchant, Arnaud Baron, Frédéric |
| author_facet | Canti, Lorenzo Ariën, Kevin K. Desombere, Isabelle Humblet-Baron, Stéphanie Pannus, Pieter Heyndrickx, Leo Henry, Aurélie Servais, Sophie Willems, Evelyne Ehx, Grégory Goriely, Stanislas Seidel, Laurence Michiels, Johan Willems, Betty Goossens, Maria E. Beguin, Yves Marchant, Arnaud Baron, Frédéric |
| author_sort | Canti, Lorenzo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8847067 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88470672022-02-16 Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients Canti, Lorenzo Ariën, Kevin K. Desombere, Isabelle Humblet-Baron, Stéphanie Pannus, Pieter Heyndrickx, Leo Henry, Aurélie Servais, Sophie Willems, Evelyne Ehx, Grégory Goriely, Stanislas Seidel, Laurence Michiels, Johan Willems, Betty Goossens, Maria E. Beguin, Yves Marchant, Arnaud Baron, Frédéric Cancer Cell Letter Elsevier Inc. 2022-04-11 2022-02-16 /pmc/articles/PMC8847067/ /pubmed/35172125 http://dx.doi.org/10.1016/j.ccell.2022.02.005 Text en © 2022 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter Canti, Lorenzo Ariën, Kevin K. Desombere, Isabelle Humblet-Baron, Stéphanie Pannus, Pieter Heyndrickx, Leo Henry, Aurélie Servais, Sophie Willems, Evelyne Ehx, Grégory Goriely, Stanislas Seidel, Laurence Michiels, Johan Willems, Betty Goossens, Maria E. Beguin, Yves Marchant, Arnaud Baron, Frédéric Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients |
| title | Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients |
| title_full | Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients |
| title_fullStr | Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients |
| title_full_unstemmed | Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients |
| title_short | Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients |
| title_sort | antibody response against sars-cov-2 delta and omicron variants after third-dose bnt162b2 vaccination in allo-hct recipients |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847067/ https://www.ncbi.nlm.nih.gov/pubmed/35172125 http://dx.doi.org/10.1016/j.ccell.2022.02.005 |
| work_keys_str_mv | AT cantilorenzo antibodyresponseagainstsarscov2deltaandomicronvariantsafterthirddosebnt162b2vaccinationinallohctrecipients AT arienkevink antibodyresponseagainstsarscov2deltaandomicronvariantsafterthirddosebnt162b2vaccinationinallohctrecipients AT desombereisabelle antibodyresponseagainstsarscov2deltaandomicronvariantsafterthirddosebnt162b2vaccinationinallohctrecipients AT humbletbaronstephanie antibodyresponseagainstsarscov2deltaandomicronvariantsafterthirddosebnt162b2vaccinationinallohctrecipients AT pannuspieter antibodyresponseagainstsarscov2deltaandomicronvariantsafterthirddosebnt162b2vaccinationinallohctrecipients AT heyndrickxleo antibodyresponseagainstsarscov2deltaandomicronvariantsafterthirddosebnt162b2vaccinationinallohctrecipients AT henryaurelie antibodyresponseagainstsarscov2deltaandomicronvariantsafterthirddosebnt162b2vaccinationinallohctrecipients AT servaissophie antibodyresponseagainstsarscov2deltaandomicronvariantsafterthirddosebnt162b2vaccinationinallohctrecipients AT willemsevelyne antibodyresponseagainstsarscov2deltaandomicronvariantsafterthirddosebnt162b2vaccinationinallohctrecipients AT ehxgregory antibodyresponseagainstsarscov2deltaandomicronvariantsafterthirddosebnt162b2vaccinationinallohctrecipients AT gorielystanislas antibodyresponseagainstsarscov2deltaandomicronvariantsafterthirddosebnt162b2vaccinationinallohctrecipients AT seidellaurence antibodyresponseagainstsarscov2deltaandomicronvariantsafterthirddosebnt162b2vaccinationinallohctrecipients AT michielsjohan antibodyresponseagainstsarscov2deltaandomicronvariantsafterthirddosebnt162b2vaccinationinallohctrecipients AT willemsbetty antibodyresponseagainstsarscov2deltaandomicronvariantsafterthirddosebnt162b2vaccinationinallohctrecipients AT goossensmariae antibodyresponseagainstsarscov2deltaandomicronvariantsafterthirddosebnt162b2vaccinationinallohctrecipients AT beguinyves antibodyresponseagainstsarscov2deltaandomicronvariantsafterthirddosebnt162b2vaccinationinallohctrecipients AT marchantarnaud antibodyresponseagainstsarscov2deltaandomicronvariantsafterthirddosebnt162b2vaccinationinallohctrecipients AT baronfrederic antibodyresponseagainstsarscov2deltaandomicronvariantsafterthirddosebnt162b2vaccinationinallohctrecipients |